XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Dec. 31, 2020 $ 5 $ 456,974 $ 9 $ (188,975) $ 268,013
Beginning balance, shares at Dec. 31, 2020 46,291,877        
Issuance of common stock upon initial public offering, net of issuance costs $ 1 211,285     211,286
Issuance of common stock upon initial public offering, net of issuance costs, shares 9,200,000        
Issuance of common stock upon exercise of stock options   2,947     2,947
Issuance of common stock upon exercise of stock options, shares 689,166        
Vesting of restricted common stock, shares 535,911        
Issuance of common stock under other equity plans   355     355
Issuance of common stock under other equity plans, shares 15,511        
Stock-based compensation expense   12,826     12,826
Unrealized losses on marketable securities     (9)   (9)
Net loss       (88,208) (88,208)
Ending balance at Sep. 30, 2021 $ 6 684,387   (277,183) 407,210
Ending balance, shares at Sep. 30, 2021 56,732,465        
Beginning balance at Jun. 30, 2021 $ 6 678,720 4 (245,328) 433,402
Beginning balance, shares at Jun. 30, 2021 56,431,513        
Issuance of common stock upon exercise of stock options   697     697
Issuance of common stock upon exercise of stock options, shares 145,646        
Vesting of restricted common stock, shares 155,306        
Stock-based compensation expense   4,970     4,970
Unrealized losses on marketable securities     (4)   (4)
Net loss       (31,855) (31,855)
Ending balance at Sep. 30, 2021 $ 6 684,387   (277,183) 407,210
Ending balance, shares at Sep. 30, 2021 56,732,465        
Beginning balance at Dec. 31, 2021 $ 6 689,866   (308,126) 381,746
Beginning balance, shares at Dec. 31, 2021 56,969,618        
Issuance of common stock upon initial public offering, net of issuance costs   12,338     12,338
Issuance of common stock upon initial public offering, net of issuance costs, shares 1,795,524        
Issuance of common stock upon exercise of stock options   $ 611     $ 611
Issuance of common stock upon exercise of stock options, shares 147,400        
Vesting of restricted common stock, shares 294,767 (394,000)     (394,000)
Issuance of common stock under other equity plans   $ 379     $ 379
Issuance of common stock under other equity plans, shares 67,860        
Stock-based compensation expense   18,605     18,605
Unrealized losses on marketable securities     (302)   (302)
Net loss       (104,234) (104,234)
Ending balance at Sep. 30, 2022 $ 6 721,405 (302) (412,360) 308,749
Ending balance, shares at Sep. 30, 2022 59,275,169        
Beginning balance at Jun. 30, 2022 $ 6 706,261 (339) (381,054) 324,874
Beginning balance, shares at Jun. 30, 2022 57,597,141        
Issuance of common stock upon initial public offering, net of issuance costs   9,617     9,617
Issuance of common stock upon initial public offering, net of issuance costs, shares 1,379,887        
Issuance of common stock upon exercise of stock options   $ 58     $ 58
Issuance of common stock upon exercise of stock options, shares 15,026        
Vesting of restricted common stock, shares 280,404 (394,000)     (394,000)
Issuance of common stock under other equity plans   $ 15     $ 15
Issuance of common stock under other equity plans, shares 2,711        
Stock-based compensation expense   5,848     5,848
Unrealized losses on marketable securities     37   37
Net loss       (31,306) (31,306)
Ending balance at Sep. 30, 2022 $ 6 $ 721,405 $ (302) $ (412,360) $ 308,749
Ending balance, shares at Sep. 30, 2022 59,275,169